Company intelligence / Profile preview

Medicode

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Medicode is a leading clinical contract research organization (CRO) based in China, providing comprehensive clinical trial services to the global pharmaceutical and biotechnology industries. Founded in 2005, the company specializes in clinical trial management, regulatory affairs, data management, and biostatistics, with a particular focus on navigating the complex regulatory landscape in China. Medicode offers full-service support for Phase I through IV clinical trials, helping domestic and international clients accelerate their drug development programs. The company is recognized for its expertise in oncology, cardiovascular, and metabolic disease research, maintaining high quality standards and a strong track record of successful regulatory submissions.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Medicode.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicode.

Explore the full profile